Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -706 | -3,659 | -2,933 | -2,072 | -952 |
| Depreciation Amortization | 110 | 296 | 195 | 36 | 19 |
| Other Working Capital | -128 | -39 | -263 | 19 | -200 |
| Other Operating Activity | 59 | 192 | 76 | 197 | 121 |
| Operating Cash Flow | $-665 | $-3,210 | $-2,925 | $-1,820 | $-1,012 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -6 | -5 | -2 |
| Investing Cash Flow | $N/A | $-5 | $-6 | $-5 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,350 | 3,350 | 500 | N/A |
| Common Stock Issued | N/A | 199 | 199 | 199 | 17 |
| Financing Cash Flow | $N/A | $3,549 | $3,549 | $699 | $17 |
| Beginning Cash Position | 1,653 | 1,318 | 1,318 | 1,318 | 1,318 |
| End Cash Position | 988 | 1,653 | 1,937 | 193 | 322 |
| Net Cash Flow | $-665 | $334 | $619 | $-1,125 | $-997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -665 | -3,210 | -2,925 | -1,820 | -1,012 |
| Capital Expenditure | N/A | -5 | -6 | -5 | -2 |
| Free Cash Flow | -665 | -3,215 | -2,931 | -1,825 | -1,013 |